BTA is now a possible T/O target - not only would most major pharmas like to include this dupoly influenza drug in their own products, but more so to GSK - why pay $3 per share when you can buy it at $0.80?
- Forums
- ASX - By Stock
- BTA
- cheaper to t/o than pay
cheaper to t/o than pay
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online